Cormorant Asset Management
GOSS icon

Cormorant Asset Management’s Gossamer Bio GOSS Stock Holding History

Cormorant Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,980
Closed -$38.3M – 74
2022
Q3 		$38.3M Buy
39,980
+37,500
+1,512% +$37.2M 2.68% 11
2022
Q2 		$1.66M Hold
2,480
– – 0.13% 64
2022
Q1 		$1.72M Hold
2,480
– – 0.13% 69
2021
Q4 		$2.24M Hold
2,480
– – 0.13% 69
2021
Q3 		$2.49M Hold
2,480
– – 0.1% 81
2021
Q2 		$1.61M Sell
2,480
-8,125
-77% -$5.64M 0.05% 95
2021
Q1 		$7.85M Hold
10,605
– – 0.17% 81
2020
Q4 		$8.2M Buy
10,605
+7,500
+242% +$5.91M 0.2% 75
2020
Q3 		$3.08M Sell
3,105
-1,262
-29% -$1.34M 0.12% 83
2020
Q2 		$4.54M Buy
4,367
+1,887
+76% +$1.9M 0.17% 72
2020
Q1 		$2.01M Sell
2,480
-1,270
-34% -$1.33M 0.09% 70
2019
Q4 		$4.69M Sell
3,750
-3,977
-51% -$6.41M 0.19% 61
2019
Q3 		$10.4M Sell
7,727
-312
-4% -$496K 0.63% 44
2019
Q2 		$14.3M Sell
8,039
-125
-2% -$191K 0.82% 38
2019
Q1 		$14.2M Buy
+8,164
New +$13.6M 0.96% 34

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Weiss Asset Management
Weiss Asset Management Boston, Massachusetts $9.5B AUM 55.06% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cormorant Asset Management's GOSS Position: Q4 2022 in Review

Cormorant Asset Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 39,980 shares — an estimated $38.3M sold.

Cormorant Asset Management first reported a position in GOSS in Q1 2019 and held it in 15 quarters. The position peaked at $38.3M in Q3 2022. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Cormorant Asset Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Cormorant Asset Management sold 39,980 Gossamer Bio shares in Q4 2022, an estimated $38.3M.
  • Cormorant Asset Management first reported a position in Gossamer Bio in Q1 2019 and held it in 15 quarters.
  • Cormorant Asset Management's Gossamer Bio position peaked at $38.3M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Cormorant Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.